BE819436A - Composition pharmaceutique renfermant des pyridylthiourees. - Google Patents

Composition pharmaceutique renfermant des pyridylthiourees.

Info

Publication number
BE819436A
BE819436A BE148123A BE148123A BE819436A BE 819436 A BE819436 A BE 819436A BE 148123 A BE148123 A BE 148123A BE 148123 A BE148123 A BE 148123A BE 819436 A BE819436 A BE 819436A
Authority
BE
Belgium
Prior art keywords
pyridylthiouraes
pharmaceutical composition
composition containing
pharmaceutical
containing pyridylthiouraes
Prior art date
Application number
BE148123A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to BE148123A priority Critical patent/BE819436A/fr
Priority to DE2441929A priority patent/DE2441929A1/de
Publication of BE819436A publication Critical patent/BE819436A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
BE148123A 1974-08-30 1974-08-30 Composition pharmaceutique renfermant des pyridylthiourees. BE819436A (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BE148123A BE819436A (fr) 1974-08-30 1974-08-30 Composition pharmaceutique renfermant des pyridylthiourees.
DE2441929A DE2441929A1 (de) 1974-08-30 1974-09-02 Arzneimittelpraeparate, in diesen praeparaten enthaltene neue wirkstoffe und verfahren zu deren herstellung

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE148123A BE819436A (fr) 1974-08-30 1974-08-30 Composition pharmaceutique renfermant des pyridylthiourees.
DE2441929A DE2441929A1 (de) 1974-08-30 1974-09-02 Arzneimittelpraeparate, in diesen praeparaten enthaltene neue wirkstoffe und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
BE819436A true BE819436A (fr) 1975-02-28

Family

ID=25648095

Family Applications (1)

Application Number Title Priority Date Filing Date
BE148123A BE819436A (fr) 1974-08-30 1974-08-30 Composition pharmaceutique renfermant des pyridylthiourees.

Country Status (2)

Country Link
BE (1) BE819436A (fr)
DE (1) DE2441929A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203988A (en) 1975-11-12 1980-05-20 Merck & Co., Inc. Pyridinyl ureas and pharmaceutical use
EP0540143A3 (fr) * 1991-08-02 1995-01-04 Medivir Ab

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4490533A (en) * 1980-12-22 1984-12-25 Merck & Co., Inc. Aminoalkyl pyridine derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203988A (en) 1975-11-12 1980-05-20 Merck & Co., Inc. Pyridinyl ureas and pharmaceutical use
EP0540143A3 (fr) * 1991-08-02 1995-01-04 Medivir Ab

Also Published As

Publication number Publication date
DE2441929A1 (de) 1976-03-11

Similar Documents

Publication Publication Date Title
DOP1980002892A (es) Composicion farmaceutica
BE817126A (fr) Composition pharmaceutique fibrinolytique
NL7512430A (nl) Microcompartimenten bevattend farmaceutisch af- leverorgaan.
NL7514012A (nl) Farmaceutische capsules.
NL7510342A (nl) Gesubstitueerde purineverbindingen en farmaceu- tische toepassing daarvan.
NL7500552A (nl) Farmaceutische preparaten.
NL7512971A (nl) Steriliseerinrichting.
FR2287223A1 (fr) Composition pharmaceutique
ES226448Y (es) Recipiente.
NL7505240A (nl) Farmaceutisch preparaat.
OA04962A (fr) Nouvelles compositions de matières.
FR2290196A1 (fr) Composition pharmaceutique
NO141049C (no) Overflateaktive forbindelser.
BE809378A (fr) Compositions pharmaceutiques comprenant des sulfonamides
FR2326189A2 (fr) Composition pharmaceutique
NL7503401A (nl) Vloeibare samenstellingen.
FR2295005A1 (fr) Nouvelles substances odoriferantes
ES223592Y (es) Recipiente.
NL7505174A (nl) Farmaceutische mengsels.
BE776769A (fr) Composition pharmaceutique
NO145193C (no) Flaskekapsel.
BE819436A (fr) Composition pharmaceutique renfermant des pyridylthiourees.
SE7711779L (sv) Farmaceutiska kompositioner
SE7504048L (sv) Behallare.
IT1036999B (it) Disinfettante anionico contenente tudio